Embio Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Private

  • Employees
  • 448

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 1

Embio General Information

Description

Manufacturer of Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals catering to global customers in the pharmaceutical, nutraceutical, food, cosmetic, crop, and plant protection segments. The company utilizes bacterial, fungal, precision fermentation, catalytic hydrogenation, and chiral chemistry, enabling the pharmaceutical and nutraceutical industries to access specialized ingredients through sustainable and regulatory-approved manufacturing processes.

Contact Information

Website
www.embio.co.in
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Sentinel, Hiranandani Gardens,, Powai
  • Mumbai, Maharashtra 400076
  • India
Primary Industry
Specialty Chemicals
Vertical(s)
Corporate Office
  • Sentinel, Hiranandani Gardens,, Powai
  • Mumbai, Maharashtra 400076
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Embio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Embio‘s full profile, request access.

Request a free trial

Embio Patents

Embio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026190796-A1 Process for preparation of lisdexamphetamine Pending 11-Mar-2025
WO-2021176381-A1 A method for preparation of diastereomeric lactate salts of 1-(1-naphthyl)ethyl amine and pure enantiomers of 1-(1-naphthyl)ethyl amine Inactive 04-Mar-2020
US-20220009899-A1 Process and compounds for preparation of cannabinoids Inactive 14-Nov-2018
WO-2020099942-A1 Process and compounds for preparation of cannabinoids Inactive 14-Nov-2018
WO-2016157065-A2 A process for preparation of dexmethylphenidate hydrochloride Inactive 03-Apr-2015 C07D211/34
To view Embio’s complete patent history, request access »

Embio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Embio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Embio‘s full profile, request access.

Request a free trial

Embio FAQs

  • When was Embio founded?

    Embio was founded in 1986.

  • Where is Embio headquartered?

    Embio is headquartered in Mumbai, India.

  • What is the size of Embio?

    Embio has 448 total employees.

  • What industry is Embio in?

    Embio’s primary industry is Specialty Chemicals.

  • Is Embio a private or public company?

    Embio is a Private company.

  • What is the current valuation of Embio?

    The current valuation of Embio is .

  • What is Embio’s current revenue?

    The current revenue for Embio is .

  • How much funding has Embio raised over time?

    Embio has raised $50.1M.

  • Who are Embio’s investors?

    HDFC Asset Management Company, State Bank of India, and True North have invested in Embio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process